What this determination covers
The National Health (Listed Drugs on F1 or F2) Amendment Determination (No. 6) 2026 is a minor amendment to the rules governing which drugs are listed on the Pharmaceutical Benefits Scheme (PBS) F1 or F2 formularies. It was made under the National Health Act 1953 by the Department of Health, Disability and Ageing.
What it amends
This determination amends the National Health (Listed Drugs on F1 or F2) Determination 2021 (PB 33 of 2021). The source does not specify which particular drugs were added, removed, or changed by this amendment.
Key dates
- Registered: 30 June 2026
- In force from: 30 June 2026
- Repealed: 17 September 2026
Where to find further detail
- The full text of this determination is available at https://www.legislation.gov.au/F2026L00885. This is the source for identifying which drugs were affected by Schedule 1 amendments to the F1 or F2 formulary between 30 June 2026 and 17 September 2026.
- The current F1 or F2 drug listings after 17 September 2026 are reflected in the latest in-force version of the National Health (Listed Drugs on F1 or F2) Determination 2021 (PB 33 of 2021), available on the Federal Register of Legislation at https://www.legislation.gov.au.
This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.